Begin main content

Adalimumab, Alefacept, Efalizumab, Etanercept, and Infliximab for Severe Psoriasis Vulgaris in Adults: Budget Impact Analysis and Review of Comparative Clinical- and Cost-Effectiveness

Last updated: December 21, 2007
Research Type: Drug
Issue: 97
Result type: Report